Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Filings indexed 916 across all filing types
Latest filing 2021-06-28 Audit Report / Informat…
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Audit Report / Information Classification · 95% confidence The document is a detailed communication from the Board of Directors of Wanbury Limited dated 28th June 2021, announcing the approval of the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31st March 2021. It includes the Auditor's Report with an unmodified opinion on these financial results. The document contains detailed audit opinions, management responsibilities, and financial disclosures typical of an audit report. It is not merely an announcement or a brief summary but includes substantive financial data and audit findings. The presence of the auditor's detailed report and the financial results for the full fiscal year indicates this is an Audit Report / Information filing rather than a full Annual Report (10-K) or a simple announcement. Therefore, the appropriate classification is AR (Audit Report / Information).
2021-06-28 English
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today has considered and approved the Audited ....
Regulatory Filings
2021-06-28 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed communication from the Board of Directors of Wanbury Limited dated 28th June 2021, announcing the approval of the Audited Financial Results for the quarter and financial year ended 31st March 2021. It includes the Auditor's Report with an unmodified opinion on these financial results, detailed audit opinions, management responsibilities, and notes on going concern and other matters. The document contains substantive financial data and analysis, including standalone and consolidated results, and is not merely an announcement or certification. The presence of the full Independent Auditor's Report and detailed financial results indicates this is the actual audited annual financial report rather than just an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K) type filing, as it covers the full financial performance for the fiscal year with audit opinions and management discussion. FY 2021
2021-06-28 English
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today has considered and approved the Audited ....
Regulatory Filings
2021-06-28 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document contains only placeholders for images and no textual content or substantive information. It is extremely short (167 characters) and does not contain any report, announcement, or detailed information. Given the lack of content, it cannot be classified as any specific report or announcement type. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous or empty filings.
2021-06-17 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2021 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2021-06-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.